Skip to content
★ Sign in to follow
WA

William A. Sullivan

CFO
Applied Genetic Technologies CorpMerrimack Pharmaceuticals Inc
Total declarations
19
Companies
2
▲ Purchases (1 ops.)
€8,791
▼ Sales (8 ops.)
€1.7M

Latest filing published 18 Dec 2018 for Applied Genetic Technologies CORP, €8,791.

Filing timeline

BuySale
William A. Sullivan

Insider track record

Disclosed buys
1
Disclosed sells
8
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

William A. Sullivan: trading record in brief

William A. Sullivan is a declared insider at 2 companies; the most frequent names are Merrimack Pharmaceuticals Inc and Applied Genetic Technologies Corp. Between 31 December 2013 and 14 December 2018, the trades on record add up to 19 filings.

Market trades split into 1 purchase (€8,791) and 8 sales (€1.7M). Netting one side against the other leaves €1.7M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 10 option exercises. So far in 2018, the count stands at 1 purchase and no sales.

The newest entry dates from 18 December 2018: an open-market purchase of €8,791, in Applied Genetic Technologies Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to William A. Sullivan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations